Foundation for Innovative New Diagnostics:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Foundation for Innovative New Diagnostics - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6410
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions. The organization has its presence in Switzerland, India, Uganda, and South Africa. FIND is headquartered in Geneva, Switzerland.

Foundation for Innovative New Diagnostics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Foundation for Innovative New Diagnostics, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Foundation for Innovative New Diagnostics, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Foundation for Innovative New Diagnostics, Medical Equipment, Deal Details 10
Partnerships 10
Chembio Diagnostics Enters into Agreement with FIND 10
Fujifilm Enters into Co-Development Contract with Foundation for Innovative New Diagnostics 11
Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 12
Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics 13
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 14
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 15
Lumora And FIND Enter Into Agreement To Develop Molecular Diagnostic Test For Malaria 16
Foundation for Innovative New Diagnostics – Key Competitors 17
Foundation for Innovative New Diagnostics – Key Employees 18
Foundation for Innovative New Diagnostics – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Government and Public Interest 20
Aug 06, 2018: Simpler diagnostic Hepatitis C test at government facilities – BERNAMA 20
Other Significant Developments 21
Aug 06, 2018: CRM-FIND MoU on innovative Hepatitis C diagnostic test – BERNAMA 21
Jul 28, 2018: FIND announces new wave of activities to address the challenges threatening hepatitis C elimination through potential diagnostic technologies 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Foundation for Innovative New Diagnostics, Medical Equipment, Key Facts 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Foundation for Innovative New Diagnostics, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Foundation for Innovative New Diagnostics, Deals By Market, 2012 to YTD 2018 8
Foundation for Innovative New Diagnostics, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Chembio Diagnostics Enters into Agreement with FIND 10
Fujifilm Enters into Co-Development Contract with Foundation for Innovative New Diagnostics 11
Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 12
Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics 13
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 14
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 15
Lumora And FIND Enter Into Agreement To Develop Molecular Diagnostic Test For Malaria 16
Foundation for Innovative New Diagnostics, Key Competitors 17
Foundation for Innovative New Diagnostics, Key Employees 18
Foundation for Innovative New Diagnostics, Other Locations 19

List of Figures
Foundation for Innovative New Diagnostics, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Foundation for Innovative New Diagnostics, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Foundation for Innovative New Diagnostics, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Foundation for Innovative New Diagnostics, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Foundation for Innovative New Diagnostics:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bashneft (BANE):企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Foodstuffs South Island Ltd:戦略・SWOT・企業財務分析
    Foodstuffs South Island Ltd - Strategy, SWOT and Corporate Finance Report Summary Foodstuffs South Island Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Intellipharmaceutics International Inc (IPCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company that researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosa …
  • Endocyte Inc (ECYT):企業の財務・戦略的SWOT分析
    Summary Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte's proprietary small molecule dr …
  • Contact Energy Ltd (CEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Contact Energy Ltd (Contact Energy) is an energy company that generates electricity and sells electricity, natural gas and liquefied petroleum gas to customers. It generates electricity from various sources of energy including thermal, hydro and geothermal sources of energy. It supplies elec …
  • Integrated Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company provides product such as xpresys lung that helps physicians to diagnose complex diseases with a non-invasive blood test. …
  • Rexnord Corp (RXN):企業の財務・戦略的SWOT分析
    Rexnord Corp (RXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • First Security Bank Inc:企業の戦略・SWOT・財務情報
    First Security Bank Inc - Strategy, SWOT and Corporate Finance Report Summary First Security Bank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Richter Gedeon Nyrt (RICHTER):企業の財務・戦略的SWOT分析
    Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Diffusion Pharmaceuticals Inc (DFFN)-製薬・医療分野:企業M&A・提携分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standard-of-care therapies. The company offers new and small-molecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for life-threat …
  • Destiny Pharma Plc (DEST):製薬・医療:M&Aディール及び事業提携情報
    Summary Destiny Pharma Plc (Destiny Pharma), formerly Destiny Pharma Ltd, a subsidiary of Destiny Pharma Holdings Ltd is a drug development and discovery company that offers commercial exploitation and clinical development of the antibacterial products. The company provides XF drug platform to addre …
  • Corporation Bank:戦略・SWOT・企業財務分析
    Corporation Bank - Strategy, SWOT and Corporate Finance Report Summary Corporation Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Partners Group Holding AG (PGHN):企業の財務・戦略的SWOT分析
    Summary Partners Group Holding AG (Partners Group) is a private market investment manager. It offers private equity and investment services. The company manages investment programs and customized portfolios for institutional investors such as insurance companies, pension funds, and sovereign wealth …
  • China General Technology (Group) Holding Ltd:企業の戦略・SWOT・財務情報
    China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Genting Bhd (GENTING):企業の財務・戦略的SWOT分析
    Genting Bhd (GENTING) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Iridium Communications Inc (IRDM):企業の財務・戦略的SWOT分析
    Iridium Communications Inc (IRDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Herantis Pharma Plc (HRTIS):医療機器:M&Aディール及び事業提携情報
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆